Article Text

Download PDFPDF
Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial
  1. Isaac Aleman1,
  2. Javier Castillo Velazquez1,
  3. Sloan W Rush2,3,
  4. Ryan B Rush1,2,3,4
  1. 1 Instituto de la Visión–Hospital La Carlota, Montemorelos, Nuevo León, México
  2. 2 Panhandle Eye Group, Amarillo, Texas, USA
  3. 3 Texas Tech University Health Science Center, Amarillo, Texas, USA
  4. 4 Southwest Retina Specialists, Amarillo, Texas, USA
  1. Correspondence to Dr Ryan B Rush, Southwest Retina Specialists, Amarillo, TX 79106, USA; ryanbradfordrush21{at}hotmail.com

Abstract

Purpose To compare the effectiveness of intravitreal ziv-aflibercept (IVZ) to intravitreal bevacizumab (IVB) administered preoperatively to patients undergoing pars plana vitrectomy (PPV) for severe manifestations of proliferative diabetic retinopathy (PDR).

Design Randomised clinical trial (RCT).

Methods Two hundred and six patients with PDR-related complications requiring PPV were randomised into one of two treatment groups: Group A received IVZ (1.25 mg/0.05 mL) 1–10 days before PPV, while Group B received IVB (1.25 mg/0.05 mL) 1–10 days before PPV. The primary outcome was best-corrected visual acuity (BCVA) at 6 months follow-up. Secondary outcome measures were perioperative tractional retinal detachment (TRD) rates, surgical times, intraoperative and postoperative complications and incidence of unplanned PPV during the 6 month study interval.

Results One hundred and seventy three subjects underwent PPV and completed the 6-month follow-up interval. Group A subjects had better BCVA at 6 months (p=0.0035), shorter surgical times (p=0.0013) and were less likely to have a recurrence of vitreous haemorrhaging in the postoperative period (p=0.0101) when compared with subjects in Group B. There were no significant differences among the treatment groups with regards to baseline characteristics, perioperative TRD development, intraoperative complications and incidence of unplanned PPV during the 6 month study interval.

Conclusions This RCT demonstrated better final visual outcomes, shorter operating times and less vitreous haemorrhage recurrences in the postoperative period when subjects received IVZ compared to IVB prior to PPV for the treatment of PDR-related complications.

  • treatment surgery
  • retina
  • clinical trial
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors Design and conduct of the study (JCV, RBR); collection, management, analysis and interpretation of the data (SWR, RBR, JCV, IA) and preparation, review or approval of the manuscript (SWR, RBR, JCV, IA).

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton Jost B Jonas James Chodosh